Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Barrett Esophagus-II: Clinical Manifestations and Management

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

Barrett Esophagus-I: Introduction

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...

Esophagus

Esophagus

The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...

Esophageal Achalasia

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...

Esophageal Strictures-II: Clinical Features and Management

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

Esophageal Strictures-I: Introduction

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dual-energy and photon-counting computed tomography in critical care.

Journal of critical care·2026

Same author

A Novel Method Using Dual-Energy Computed Tomography for Detecting Amiodarone-Induced Lung Injury: A Cohort Pilot Study.

Respirology (Carlton, Vic.)·2025

Same author

D-cycloserine effects on COPD and depression in a murine experimental model.

Frontiers in pharmacology·2025

Same author

Amivantamab as a salvage therapy post-EGFR-tyrosine kinase inhibitor failure in patients with mutated EGFR non-small cell lung cancer.

Translational lung cancer research·2025

Same author

Post-contrast acute kidney injury in the super-elder patients: a CT-scan perspective.

Japanese journal of radiology·2024

Same author

Radiological artificial intelligence - predicting personalized immunotherapy outcomes in lung cancer.

NPJ precision oncology·2023

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Staging esophageal cancer.

Leslie Eisenbud Quint¹, Naama R Bogot

¹Department of Radiology, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0030, USA. lequint@umich.edu

Cancer Imaging : the Official Publication of the International Cancer Imaging Society

|October 15, 2008

Summary

Accurate esophageal cancer staging requires multiple imaging methods. Computed tomography (CT), endoscopic ultrasonography (EUS), and positron emission tomography (PET) scans help determine disease extent for effective treatment planning.

More Related Videos

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Related Experiment Videos

Last Updated: Jun 29, 2026

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Area of Science:

Oncology
Medical Imaging
Gastroenterology

Background:

Accurate staging is crucial for esophageal cancer treatment decisions.
Current staging methods have limitations in fully assessing disease extent.

Purpose of the Study:

To review the roles of different imaging modalities in esophageal cancer staging.
To emphasize the necessity of a multimodality approach for optimal staging.

Main Methods:

Review of computed tomography (CT) for local invasion and distant metastases.
Evaluation of endoscopic ultrasonography (EUS) for tumor depth and lymph node assessment.
Assessment of positron emission tomography (PET) scanning for occult metastases.

Main Results:

CT evaluates local spread (T4) and distant metastases (M1).
EUS differentiates superficial (T1) from deeper tumors and identifies nodal disease (N1).
PET scanning is effective for detecting occult distant metastases.

Conclusions:

Optimal esophageal cancer staging necessitates a combination of imaging techniques.
Multimodality imaging ensures comprehensive assessment for appropriate therapy selection.